0001558370-23-003716 Sample Contracts

Consulting Agreement

Consulting Agreement • March 14th, 2023 • Sigilon Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts

• Contract Type
  Consulting Agreement
• Filed
  March 14th, 2023
• Company
  Sigilon Therapeutics, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  Massachusetts

This Consulting Agreement (the “Agreement”), is made as of February 14, 2023 (the “Effective Date”) by and between Sigilon Therapeutics, Inc. (the “Company”), with offices at 100 Binney Street, Suite 600, Cambridge, MA 02142, and Rare Disease and Oncology Consulting, LLC/ May Orfali, MD, MBA (the “Consultant”).

Restricted Stock Unit Agreement

Restricted Stock Unit Agreement • March 14th, 2023 • Sigilon Therapeutics, Inc. • Pharmaceutical preparations

• Contract Type
  Restricted Stock Unit Agreement
• Filed
  March 14th, 2023
• Company
  Sigilon Therapeutics, Inc.
• Industry
  Pharmaceutical preparations

This agreement (this “Agreement”) evidences a grant (the “Award”) of Restricted Stock Units (“RSUs”) by Sigilon Therapeutics, Inc., a Delaware corporation (the “Company”), to the individual named above (the “Participant”), pursuant to and subject to the terms of the Sigilon Therapeutics, Inc. 2020 Equity Incentive Plan (as from time to time amended and in effect, the “Plan”). Except as otherwise defined herein, all capitalized terms used herein have the same meaning as in the Plan.